EV-100

N/A

Report date: 2025/01/26 19:26:56
NME

Base Information

Drug NameEV-100
Drug Alias Namesirtuin -2 inhibitor (Evrys Bio)Sirtuin Modulators (FORGE Life Science)SIRT-2 inhibitor (FORGE Life Science)EV-100
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNAD-dependent protein deacetylase sirtuin-2 inhibitors
TargetsNAD-dependent protein deacetylase sirtuin-2
Therapy Area/IndicationsCytomegalovirus InfectionsVirus DiseasesLeukoencephalopathy, Progressive Multifocal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEvrys Bio Llc
China Registration ClassN/A

Develop Information

Active CompaniesEvrys Bio Llc
Inactive CompaniesN/A
Active IndicationsCytomegalovirus InfectionsVirus DiseasesLeukoencephalopathy, Progressive Multifocal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A